AOD-9604 + Tesamorelin + MOTS-c
Also known as: Fat Burner Stack, Fat Burner Blend, Metabolic Fat Loss Stack
A three-mechanism metabolic stack targeting fat loss through direct lipolysis, GH-mediated visceral-fat reduction, and mitochondrial optimization.
Components
How it's combined
Research framing layers three distinct pathways: AOD-9604 (an HGH fragment promoting lipolysis), Tesamorelin (GHRH analog reducing visceral fat), and MOTS-c (a mitochondrial peptide activating AMPK and improving insulin sensitivity). Evidence is uneven (Tesamorelin is FDA-approved; AOD-9604's Phase 2 efficacy was weak; MOTS-c is preclinical), and no combination trials exist.
Available from vendors
PeptideChat is an independent research resource, not the seller. Links go to third-party vendors; products are sold strictly as research chemicals and are not intended for human consumption.
Independent research resource
Not a seller — PeptideChat doesn't sell or ship products.
Research-use-only framing
Content is educational, not a dosing recommendation.
Vendor links clearly disclosed
Outbound links to third-party vendors are always labeled.